| Structure |
Chemical Name |
CAS |
MF |
 |
ISO-MALATHION |
3344-12-5 |
C10H19O6PS2 |
 |
Citalopram hydrochloride |
85118-27-0 |
C20H22ClFN2O |
 |
exo-Granisetron (Granisetron Impurity F) |
127472-42-8 |
C18H24N4O |
 |
dacisteine |
18725-37-6 |
C7H11NO4S |
 |
OXOLINIC ACID IMPURITY B |
16172-03-5 |
C15H15NO5 |
 |
DESETHYLENE CIPROFLOXACIN, HYDROCHLORIDE |
528851-31-2 |
C15H16FN3O3.ClH |
 |
(±)-2-methyl-1-nitrosoindoline |
85440-79-5 |
C9H10N2O |
 |
(5alpha)-7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one |
508-54-3 |
C18H19NO4 |
 |
Desmethyl Chlorpheniramine Maleate Salt |
22630-25-7 |
C19H21ClN2O4 |
 |
4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSE |
50468-56-9 |
C12H22O11 |
 |
Morphine Sulfate |
6211-15-0 |
C34H50N2O15S |
 |
1-(3-Chlorophenyl)-2-hydroxy-1-propanone |
152943-33-4 |
C9H9ClO2 |
 |
3-Oxo Ropinirole Hydrochloride
|
221264-21-7 |
C16H23ClN2O2 |
 |
7-hydroxy-2-methyl-4H-chromen-4-one |
6320-42-9 |
C10H8O3 |
 |
Desisobutyryl Ciclesonide |
161115-59-9 |
C28H38O6 |
![Des[2-[(2-Hydroxyethyl)aMino]ethyl] Mitoxantrone
(Mitoxantrone IMpurity A)](/CAS/GIF/89991-52-6.gif) |
Des[2-[(2-Hydroxyethyl)aMino]ethyl] Mitoxantrone
(Mitoxantrone IMpurity A) |
89991-52-6 |
C18H19N3O5 |
 |
OXYBUTYNIN IMPURITY A |
1199574-71-4 |
C22H35NO3 |
 |
PHENYTOIN RELATED COMPOUND B (50 MG) (AL-PHA-((AMINOCARBONYL)AMINO)-ALPHA-PHENYL BEN-ZENEACETIC ACID) |
6802-95-5 |
C15H14N2O3 |
 |
CLEBOPRIDE MALATE |
57645-91-7 |
C20H24ClN3O2.C4H6O5 |
 |
1-(3-Chlorophenyl)-1-hydroxy-2-propanone |
857233-13-7 |
C9H9ClO2 |
 |
3S, 5S enantioMer of Atorvastatin CalciuM |
1105067-88-6 |
C33H34CaFN2O5+ |
![Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)](/CAS/GIF/1026353-20-7.gif) |
Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid) |
1026353-20-7 |
C33H30N4O2 |
 |
EPOXIDIZED LINSEED OIL |
8016-11-3 |
|
 |
LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE) |
27244-64-0 |
C9H11NO5 |
 |
3-Nitro-4-phenoxy-5-sulfaMoylbenzoic Acid |
28328-53-2 |
C13H10N2O7S |
 |
ALLOPURINOL IMPURITY C |
1346604-13-4 |
C6H6N6O |
 |
PEAK E |
132685-02-0 |
C24H26N4O4 |
 |
Chlorcyclizine hydrochloride |
14362-31-3 |
C18H22Cl2N2 |
![1-[4-(2-Hydroxyethyl)phenoxy]-2,3-epoxypropane](/StructureFile/ChemBookStructure20/GIF/CB3947391.gif) |
1-[4-(2-Hydroxyethyl)phenoxy]-2,3-epoxypropane |
63659-17-6 |
C15H20O3 |
 |
Almagate |
66827-12-1 |
CH6AlMgO4(-3) |
 |
Loperamide |
106900-12-3 |
C29H33ClN2O3 |
![L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-](/CAS/GIF/2410-93-7.gif) |
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]- |
2410-93-7 |
C20H21N7O6 |
 |
2-(Acetylsulfanyl)ethanesulphonic |
69536-71-6 |
C4H8O4S2 |
![rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol](/CAS/GIF/56718-76-4.gif) |
rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol |
56718-76-4 |
C12H17ClO3 |
 |
Albuterol Aldehyde |
156339-88-7 |
C13H19NO3 |
 |
4-phenylbutylphosphonic acid |
46348-61-2 |
C10H15O3P |
 |
17R-Drospirenone |
90457-65-1 |
C24H30O3 |
![Trandolapril Related Compound D (25 mg) ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate)](/CAS/GIF/149881-40-3.gif) |
Trandolapril Related Compound D (25 mg) ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate) |
149881-40-3 |
C24H32N2O4 |
 |
Benzoic acid, 2-(hexahydro-1-Methyl-1H-azepin-4-yl)hydrazide |
110406-94-5 |
C14H21N3O |
 |
D-PENICILLAMINE DISULFIDE |
20902-45-8 |
C10H20N2O4S2 |
 |
DESETHYL CHLOROQUINE |
1476-52-4 |
C16H22ClN3 |
|
|
HIDE POWDER |
|
|
 |
BETAMETHASONE BENZOATE (200 MG) |
22298-29-9 |
C35H41FO8 |
 |
TIZANIDINE RELATED COMPOUND B (50 MG) (N-ACETYLTIZANIDINE) |
173532-15-5 |
C11H10ClN5OS |
 |
9,11-Didehydroestriol |
246021-20-5 |
C18H22O3 |
![1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine](/CAS/GIF/97928-18-2.gif) |
1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine |
97928-18-2 |
C19H29NO2 |
 |
benazepril hydrochloride |
215447-89-5 |
C24H28N2O5HCl |
 |
L-Nateglinide |
105816-05-5 |
C19H27NO3 |
 |
cis-Tranylcypromine hydrochloride |
54779-58-7 |
C9H12ClN |
 |
(1S–4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride |
172015-79-1 |
C11H12ClN5O.ClH |
 |
Atorvastatin Related Compound C |
693793-53-2 |
C33H36CaF2N2O5 |
![[2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)](/CAS/GIF/75755-10-1.gif) |
[2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid) |
75755-10-1 |
C7H11NO6P2 |
 |
2,2'-Binaphthalene-6,6'-dicarboxylic Acid |
932033-58-4 |
C22H14O4 |
 |
INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS) |
63968-75-2 |
C16H14ClN3O3S |
 |
Gabapentin Related Compound D |
1076198-17-8 |
C18H29NO3 |
 |
Vardenafil hydrochloride trihydrate |
330808-88-3 |
C23H35ClN6O5S |
 |
Norglipin |
16444-19-2 |
C21H23NO3 |
![4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid](/CAS/GIF/5623-18-7.gif) |
4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid |
5623-18-7 |
C15H14N6O3 |
 |
2-(3-CARBOXYPHENYL)PROPIONIC ACID |
68432-95-1 |
C10H10O4 |
 |
rac 5-Desfluoro Voriconazole |
182369-73-9 |
C16H15F2N5O |
 |
3-Oxo Ziprasidone
(Ziprasidone Impurity B) |
1159977-56-6 |
C21H19ClN4O2S |
 |
Desfluoro Risperidone |
106266-09-5 |
C23H28N4O2 |
 |
Des(2,3-dihydroxypropyl) Iodixanol |
255376-57-9 |
C32H38I6N6O13 |
 |
DAUNOMYCINONE |
21794-55-8 |
C21H18O8 |
 |
Duloxetine IMpurity A |
947686-09-1 |
C25H23NO3S |
 |
Labetalol IMpurity A |
1391051-99-2 |
C19H23NO4 |
 |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
 |
6,6'-DiMethoxy-2,2'-binaphthalene |
29619-45-2 |
C22H18O2 |
 |
FLUCONAZOLE RELATED COMPOUND B (10 MG) (2-(4-FLUOROPHENYL)-1,3-BIS(1 H-1,2,4-TRIAZOL-1 -YL)-PROPAN-2-OL) |
81886-51-3 |
C13H13FN6O |
 |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
 |
Levomepromazine hydrochloride |
1236-99-3 |
C19H24N2OS.ClH |
 |
Prednisolone 21-trimethylacetate |
1107-99-9 |
C26H36O6 |
 |
C00984 |
3646-73-9 |
C6H12O6 |
 |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
 |
Aripiprazole N1-Oxide |
573691-09-5 |
C23H27Cl2N3O3 |
 |
N-De(4-sulfonaMidophenyl)-N'-(4-sulfonaMidophenyl) Celecoxib |
331943-04-5 |
C17H14F3N3O2S |
![Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)](/CAS/20180808/GIF/61709-33-9.gif) |
Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) |
61709-33-9 |
C16H15Cl3N2OS |
![5-[2-Ethoxy-5-[(4-Methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-(2-Methylpropyl)-7H-pyrazolo[4,3-d]pyriMidin-7-one](/CAS/20130318/GIF/CB12622733.gif) |
5-[2-Ethoxy-5-[(4-Methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-(2-Methylpropyl)-7H-pyrazolo[4,3-d]pyriMidin-7-one |
1391053-95-4 |
C23H32N6O4S |
 |
Loratadine EP IMpurity F |
125743-80-8 |
C22H24ClFN2O2 |
![N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE](/StructureFile/ChemBookStructure9/GIF/CB1271199.gif) |
N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE |
1076198-18-9 |
C15H21N3O3S |
![HALOPERIDOL RELATED COMPOUND A (15 MG) (4,4'-BIS[(4-P-CHLOROPHENYL)-4-HYDROXY-PIPERIDINO]-BU-TYROPHENONE)](/CAS/GIF/67987-08-0.gif) |
HALOPERIDOL RELATED COMPOUND A (15 MG) (4,4'-BIS[(4-P-CHLOROPHENYL)-4-HYDROXY-PIPERIDINO]-BU-TYROPHENONE) |
67987-08-0 |
C32H36Cl2N2O3 |
 |
5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid |
2280-89-9 |
C9H7I3N2O3 |
 |
OXITROPIUM BROMIDE |
30286-75-0 |
C19H26BrNO4 |
 |
Dehydronitrendipine |
89267-41-4 |
C18H18N2O6 |
 |
4-Benzyl Albuterol |
56796-66-8 |
C20H27NO3 |
 |
cephaeline hydrochloride |
5853-29-2 |
C28H39ClN2O4 |
 |
Coenzyme |
45127-11-5 |
C4H10O6S4 |
![7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID](/CAS/GIF/106447-44-3.gif) |
7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID |
106447-44-3 |
C10H12N2O3S |
 |
2,6-Diisopropyl-1,4-benzoquinone |
1988-11-0 |
C12H16O2 |
 |
Repaglinide EP Impurity E |
147852-26-4 |
C27H36N2O4 |
![Gemfibrozil Related Compound A ,(E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid](/CAS/20180713/GIF/500904-61-0.gif) |
Gemfibrozil Related Compound A ,(E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid |
500904-61-0 |
C18H26O3 |
 |
Atorvastatin Related Compound A |
433289-83-9 |
C33H35CaN2O5+ |
 |
4-DesMethyl-3-Methyl Celecoxib |
170570-01-1 |
C17H14F3N3O2S |
 |
6-O-METHYLCODEINE |
2859-16-7 |
C19H23NO3 |
 |
Prednisolone tebutate |
7681-14-3 |
C27H38O6 |
 |
ACETOPHENAZINE MALEATE (200 MG) |
5714-00-1 |
C53H64N6O11S2 |
 |
apovincamine |
4880-92-6 |
C21H24N2O2 |
 |
4-cyclohexyl-alpha-methylnaphthalene-1-acetic acid |
71109-09-6 |
C19H22O2 |
 |
eicosapentaenoic acid ethyl ester |
73310-10-8 |
C22H34O2 |
 |
SalMeterol Xinafoate Adduct IMpurity |
1330076-52-2 |
C36H43NO6 |